新規登録 | ログイン | FAQ      [?] 

タグ: neuroblastoma [44 articles]

Recent papers classified by the tag neuroblastoma.
  • High expressions of neuronatin isoforms in favorable neuroblastoma.
    J Pediatr Hematol Oncol, Vol. 29, No. 8. (August 2007), pp. 551-556.
    by M Higashi, T Tajiri, Y Kinoshita, K Tatsuta, R Souzaki, Y Maehara, S Suita, T Taguchi
    posted to adrenal cancer human neuroblastoma nnat by rschulz on 2008-02-22 08:38:43 as **
  • Antiangiogenic strategies in neuroblastoma.
    Cancer Treat Rev, Vol. 31, No. 1. (February 2005), pp. 27-34.
    by D Ribatti, M Ponzoni
    posted to angiogenesis neuroblastoma review by rfrousse on 2005-06-28 06:14:22 as **** along with 2 groups Institut_Hemato_Oncologie_Pediatrique Neuroblastome_SFCE
  • Role of genomics-based strategies in overcoming chemotherapeutic resistance.
    Curr Pharm Biotechnol, Vol. 5, No. 5. (October 2004), pp. 471-480.
    by MV Kumar, R Shirley, Y Ma, RW Lewis
    posted to chimioresistance neuroblastoma pharmaco-genomics review by rfrousse on 2005-06-28 06:17:10 as ** along with 2 groups Institut_Hemato_Oncologie_Pediatrique Neuroblastome_SFCE
  • Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.
    Cancer Cell, Vol. 6, No. 6. (December 2004), pp. 625-630.
    by S Valsesia-Wittmann, M Magdeleine, S Dupasquier, E Garin, AC Jallas, V Combaret, A Krause, P Leissner, A Puisieux
    posted to mycn neuroblastoma twist by rfrousse on 2005-06-28 06:26:24 as read along with 2 groups Institut_Hemato_Oncologie_Pediatrique Neuroblastome_SFCE
  • Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
    J Clin Oncol, Vol. 23, No. 10. (1 April 2005), pp. 2280-2299.
    by J Vandesompele, M Baudis, K De Preter, N Van Roy, P Ambros, N Bown, C Brinkschmidt, H Christiansen, V Combaret, M Lastowska, J Nicholson, A O'Meara, D Plantaz, R Stallings, B Brichard, C Van den Broecke, S De Bie, A De Paepe, G Laureys, F Speleman
    posted to 17 cgh chromosome neuroblastoma stratification by rfrousse on 2005-06-28 06:05:07 as read along with 2 groups Institut_Hemato_Oncologie_Pediatrique Neuroblastome_SFCE
  • Neuroblastoma update.
    Curr Opin Oncol, Vol. 17, No. 1. (January 2005), pp. 19-23.
    by MC Henry, DB Tashjian, CK Breuer
    posted to neuroblastoma review by rfrousse on 2005-06-28 06:16:11 as *** along with 2 groups Institut_Hemato_Oncologie_Pediatrique Neuroblastome_SFCE
  • The biologic basis for neuroblastoma heterogeneity and risk stratification.
    Curr Opin Pediatr, Vol. 17, No. 1. (February 2005), pp. 7-13.
    by JM Maris
    posted to neuroblastoma review stratification by rfrousse on 2005-06-28 06:15:01 as *** along with 2 groups Institut_Hemato_Oncologie_Pediatrique Neuroblastome_SFCE
  • KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity.
    Cell, Vol. 125, No. 2. (21 April 2006), pp. 371-383.
    by R Midorikawa, Y Takei, N Hirokawa
    posted to kif4 neuroblastoma parp survival by ieken on 2006-05-16 02:44:59 as read
  • Recurrent pelvic neuroblastoma in an adult patient.
    Gynecol Oncol (25 April 2007)
    by Andreas Loeser, Elmar W W Gerharz, Hubertus Riedmiller
    posted to adult neuroblastoma by hjmykt on 2007-05-15 14:03:46 as *****
  • Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo
    Oncogene, Vol. aop, No. current.
    by JI Johnsen, L Segerström, A Orrego, L Elfman, M Henriksson, B Kågedal, S Eksborg, B Sveinbjörnsson, P Kogner
    posted to angiogeneis apoptosis mycn neuroblastoma rapamycin regulation by fpattyn to the group Neuroblastoma on 2007-11-21 23:21:24 as **
  • p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells
    Nucl. Acids Res., Vol. 36, No. 13. (1 August 2008), pp. 4222-4232.
    by Emilie Horvilleur, Matthieu Bauer, David Goldschneider, Xenia Mergui, de La, Jean Benard, Setha Douc-Rasy, David Cappellen
    posted to mycn neuroblastoma p73 post-transcriptional regulation tp73 transcriptional by fpattyn to the group Neuroblastoma on 2008-07-23 16:15:40 as **
  • Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells
    Molecular Cancer, Vol. 7 (12 June 2008), 55.
    by Annick Muhlethaler-Mottet, Roland Meier, Marjorie Flahaut, Katia B Bourloud, Katya Nardou, Jean-Marc Joseph, Nicole Gross
    posted to deacytelase histone inhibitors neuroblastoma by fpattyn to the group Neuroblastoma on 2008-06-14 06:47:28 as **
  • Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification.
    Proc Natl Acad Sci U S A, Vol. 101, No. 34. (24 August 2004), pp. 12664-12669.
    by LM Hansford, WD Thomas, JM Keating, CA Burkhart, AE Peaston, MD Norris, M Haber, PJ Armati, WA Weiss, GM Marshall
    posted to development mice mycn neuroblastoma transgenic by fpattyn to the group Neuroblastoma on 2007-11-22 14:30:11 as **
  • Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells
    Oncogene, Vol. aop, No. current.
    by KB Grandinetti, BA Spengler, JL Biedler, RA Ross
    posted to elavl4 mycn neuroblastoma by fpattyn to the group Neuroblastoma on 2007-12-11 16:14:43 as **
  • In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin
    Oncogene, Vol. aop, No. current.
    by F Bourdeaut, A Ribeiro, R Paris, G Pierron, J Couturier, M Peuchmaur, O Delattre
    posted to neuroblast neuroblastoma by fpattyn to the group Neuroblastoma on 2008-05-08 15:52:31 as **
  • Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN.
    Int J Cancer, Vol. 122, No. 7. (4 December 2007), pp. 1455-1464.
    by Arjen Koppen, Rachida Ait-Aissa, Jan Koster, Ingrid Ora, Johannes Bras, Peter G G van Sluis, Huib Caron, Rogier Versteeg, Linda J J Valentijn
    posted to dkk3 mycn neuroblastoma by fpattyn to the group Neuroblastoma on 2008-01-31 14:53:32 as **
  • MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
    Oncogene, Vol. aop, No. current.
    by C Welch, Y Chen, RL Stallings,
    posted to mirna neuroblastoma by fpattyn to the group Neuroblastoma on 2008-01-25 16:26:00 as ** along with 2 people tardigrade maralena
  • Origin and functional significance of large-scale chromosomal imbalances in neuroblastoma.
    Cytogenet Genome Res, Vol. 118, No. 2-4. (2007), pp. 110-115.
    by RL Stallings
    posted to acgh chromosomal imbalance neuroblastoma by fpattyn to the group Neuroblastoma on 2007-11-21 12:57:27 as **
  • A Systematic Review of Molecular and Biological Tumor Markers in Neuroblastoma
    Clin Cancer Res, Vol. 10, No. 1. (1 January 2004), pp. 4-12.
    by Richard D Riley, David Heney, David R Jones, Alex J Sutton, Paul C Lambert, Keith R Abrams, Bridget Young, Alan J Wailoo, Susan A Burchill
    posted to markers neuroblastoma by fpattyn to the group Neuroblastoma on 2007-11-20 10:10:50 as **
  • Binding of a 40-kDa protein to the N-myc 3'-untranslated region correlates with enhanced N-myc expression in human neuroblastoma.
    J Biol Chem, Vol. 271, No. 52. (27 December 1996), pp. 33580-33586.
    by D Chagnovich, SL Cohn
    posted to elavl4 mycn neuroblastoma by fpattyn to the group Neuroblastoma on 2007-12-12 16:20:31 as **
  • New miRNAs cloned from neuroblastoma
    BMC Genomics, Vol. 9, No. 1. (2008)
    by Elena Afanasyeva, Agnes H Wagenblatt, Karl H Glatting, Frank Westermann
    posted to expression gene mirna neuroblastoma by fpattyn to the group Neuroblastoma on 2008-04-06 19:27:04 as ** along with 1 person and 1 group heliopais microRNA
  • Neuroblastoma - a developmental perspective
    Cancer Letters, Vol. 197, No. 1-2. (18 July 2003), pp. 3-9.
    by Carmel M Mcconville, Joan Forsyth
    posted to development neuroblastoma by fpattyn to the group Neuroblastoma on 2007-11-20 10:07:12 as **
  • Cathepsin D Protects Human Neuroblastoma Cells from Doxorubicin-Induced Cell Death.
    Carcinogenesis (19 June 2008)
    by Vitalia Sagulenko, Daniel Muth, Evgeny Sagulenko, Tobias Paffhausen, Manfred Schwab, Frank Westermann
    posted to chip ctsd doxorubicin mycn neuroblastoma by fpattyn to the group Neuroblastoma on 2008-06-22 21:30:32 as **
  • Differential activity of ELAV-like RNA-binding proteins in human neuroblastoma.
    J Biol Chem, Vol. 271, No. 52. (27 December 1996), pp. 33587-33591.
    by D Chagnovich, BE Fayos, SL Cohn
    posted to elavl4 neuroblastoma by fpattyn to the group Neuroblastoma on 2007-12-12 16:20:49 as **
  • Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
    Clin Cancer Res, Vol. 3, No. 10. (October 1997), pp. 1859-1865.
    by NS Ball, PH King
    posted to elavl4 neuroblastoma by fpattyn to the group Neuroblastoma on 2007-12-11 16:07:45 as **
  • Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas
    Oncogene, Vol. aop, No. current.
    by Y Sugino, A Misawa, J Inoue, M Kitagawa, H Hosoi, T Sugimoto, I Imoto, J Inazawa
    posted to epigenetics neuroblastoma ptger2 by fpattyn to the group Neuroblastoma on 2007-11-22 16:25:27 as **
  • Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor.
    J Neurosci, Vol. 14, No. 4. (April 1994), pp. 1943-1952.
    by PH King, TD Levine, RT Fremeau, JD Keene
    posted to elavl4 neuroblastoma by fpattyn to the group Neuroblastoma on 2007-12-12 16:21:01 as **
  • HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells.
    Eur J Cancer, Vol. 33, No. 12. (October 1997), pp. 2071-2074.
    by RA Ross, DL Lazarova, GT Manley, PS Smitt, BA Spengler, JB Posner, JL Biedler
    posted to elavl4 mycn neuroblastoma by fpattyn to the group Neuroblastoma on 2007-12-11 16:10:36 as **
  • The MYCN oncoprotein as a drug development target
    Cancer Letters, Vol. 197, No. 1-2. (18 July 2003), pp. 125-130.
    by Xiaohong Lu, Andrew Pearson, John Lunec
    posted to mycn neuroblastoma therapy by fpattyn on 2007-11-22 14:27:19 as ** along with 1 group Neuroblastoma
  • Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma.
    J Mol Diagn, Vol. 9, No. 2. (April 2007), pp. 237-241.
    by IY Cheung, Y Feng, A Vickers, W Gerald, NK Cheung
    posted to cyclin-d1 neuroblastoma by eisei on 2007-06-12 17:30:49 as **
  • Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma.
    Genes Chromosomes Cancer, Vol. 36, No. 3. (March 2003), pp. 242-249.
    by JJ Molenaar, P van Sluis, K Boon, R Versteeg, HN Caron
    posted to cyclin-d1 neuroblastoma by eisei on 2007-06-12 17:24:22 as **
  • Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
    Genome Biology, Vol. 7 (21 September 2006), R84.
    by Katleen De Preter, Jo Vandesompele, Pierre Heimann, Nurten Yigit, Siv Beckman, Alexander Schramm, Angelika Eggert, Raymond L Stallings, Yves Benoit, Marleen Renard, Anne De Paepe, Genevieve Laureys, Sven Pahlman, Frank Speleman
    posted to neuroblastoma by barriot on 2008-03-04 19:43:09 as **
  • Mass screening for neuroblastoma at 6 months of age - Authors' reply.
    Lancet, Vol. 372, No. 9636. (2 August 2008)
    by Eiso Hiyama, Tomoko Iehara
    posted to neuroblastoma by Amazoness on 2008-08-12 02:49:39 as **
  • Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen.
    Cancer immunology, immunotherapy : CII, Vol. 57, No. 11. (November 2008), pp. 1625-1634.
    by M Croce, R Meazza, AM Orengo, M Fabbi, M Borghi, D Ribatti, B Nico, B Carlini, V Pistoia, MV Corrias, S Ferrini
    posted to neuroblastoma immunotherapy il-21 by Amazoness on 2008-09-05 10:09:25 as **
  • Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma.
    Cancer research, Vol. 68, No. 14. (15 July 2008), pp. 5979-5987.
    by RM Donev, LC Gray, B Sivasankar, TR Hughes, CW van den Berg, BP Morgan
    posted to immunotherapy neuroblastoma by Amazoness on 2008-07-22 00:17:50 as **
  • Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma.
    The New England journal of medicine (7 May 2008)
    by John M M Maris, Yael P P Mosse, Jonathan P P Bradfield, Cuiping Hou, Stefano Monni, Richard H H Scott, Shahab Asgharzadeh, Edward F F Attiyeh, Sharon J J Diskin, Marci Laudenslager, Cynthia Winter, Kristina A A Cole, Joseph T T Glessner, Cecilia Kim, Edward C C Frackelton, Tracy Casalunovo, Andrew W W Eckert, Mario Capasso, Eric F F Rappaport, Carmel McConville, Wendy B B London, Robert C C Seeger, Nazneen Rahman, Marcella Devoto, Struan F A F Grant, Hongzhe Li, Hakon Hakonarson
    posted to neuroblastoma by Amazoness on 2008-05-13 04:17:24 as **
  • A case series of children with high-risk metastatic neuroblastoma treated with a novel treatment strategy consisting of postponed primary surgery until the end of systemic chemotherapy including high-dose chemotherapy.
    Pediatric hematology and oncology, Vol. 25, No. 5. (June 2008), pp. 439-450.
    by Y Hashii, T Kusafuka, H Ohta, A Yoneda, Y Osugi, Y Kobayashi, M Fukuzawa, J Hara
    posted to neuroblastoma by Amazoness on 2008-08-13 02:29:11 as **
  • Stem cell transplantation for neuroblastoma
    Bone Marrow Transplantation, Vol. aop, No. current.
    by JD Fish, SA Grupp
    posted to sct neuroblastoma by Amazoness on 2008-09-05 10:08:03 as **
  • Screening for neuroblastoma: a resurrected idea?
    Lancet, Vol. 371, No. 9619. (5 April 2008), pp. 1142-1143.
    by JM Maris, WG Woods
    posted to neuroblastoma by Amazoness on 2008-04-11 07:48:09 as **
  • Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
    Lancet, Vol. 371, No. 9619. (5 April 2008), pp. 1173-1180.
    by E Hiyama, T Iehara, T Sugimoto, M Fukuzawa, Y Hayashi, F Sasaki, M Sugiyama, S Kondo, A Yoneda, H Yamaoka, T Tajiri, K Akazawa, M Ohtaki
    posted to neuroblastoma by Amazoness on 2008-04-11 07:49:22 as **
  • Neuroblastoma -- Linking a Common Allele to a Rare Disease.
    The New England journal of medicine (7 May 2008)
    by Brian H H Kushner, Nai-Kong V K Cheung
    posted to neuroblastoma by Amazoness on 2008-05-13 04:16:48 as **
  • Resting energy expenditure in children newly diagnosed with stage IV neuroblastoma.
    Pediatric research, Vol. 63, No. 3. (March 2008), pp. 332-336.
    by GJ Green, SS Weitzman, PB Pencharz
    posted to neuroblastoma by Amazoness on 2008-06-10 08:28:03 as **
  • Neuroblastoma.
    Lancet, Vol. 369, No. 9579. (23 June 2007), pp. 2106-2120.
    by JM Maris, MD Hogarty, R Bagatell, SL Cohn
    posted to neuroblastoma by Amazoness on 2008-06-06 07:18:06 as **
  • A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity.
    Molecular cancer therapeutics, Vol. 7, No. 7. (July 2008), pp. 2241-2251.
    by N Huebener, S Fest, A Strandsby, E Michalsky, R Preissner, Y Zeng, G Gaedicke, HN Lode
    posted to immunity neuroblastoma by Amazoness on 2008-07-24 07:12:17 as ** along with 1 person reyez
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/tag/neuroblastoma

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.